medigraphic.com
ISSN 2007-6053 (Impreso)
Órgano oficial de difusión de los Hospitales Regionales de Alta Especialidad (HRAE)

2013, Número 3

<< Anterior Siguiente >>

Evid Med Invest Salud 2013; 6 (3)


Epidemiología del síndrome metabólico en pediatría

Cornejo BJ, Llanas RJD

Idioma: Español
Referencias bibliográficas: 39
Paginas: 89-94
Archivo PDF: 331.88 Kb.


RESUMEN

La magnitud del síndrome metabólico en pediatría es variable y depende de los criterios diagnósticos, de la población estudiada y del estado nutricional principalmente. Desde el 2007 la Federación Internacional de Diabetes define los criterios, es decir, no existen para menores de 10 años, en los niños de 10 - 16 años considera: la alteración en el metabolismo de la glucosa, la obesidad abdominal, el aumento en la presión arterial, la hipertrigliceridemia y la disminución del colesterol HDL y en mayores de 16 años los criterios son los mismos que en la población adulta. La prevalencia en México en general oscila desde 1.6% en adolescentes de Tuxtla Gutiérrez, Chiapas en el 2005 hasta el 20% en Campeche y Ciudad Victoria, Tamaulipas en el 2010 y 2011, respectivamente. La frecuencia del síndrome metabólico es mayor en niños con obesidad.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988; 37: 1595-607.

  2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med. 1998; 15: 539-53.

  3. Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin N Am. 2004; 33: 283-303.

  4. Cruz ML, Weigensberg MJ, Huang TTK, Ball G, Shaibi GQ, Goran MI. The metabolic syndrome in overweight hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab. 2004; 89: 108-13.

  5. Ten S, MacLaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab. 2004; 89: 2526-39.

  6. Chiarelli F, Marcovecchio ML. Insulin resistance and obesity in childhood. Eur J Endocrinol. 2008; 159 (Suppl 1): S67-S74.

  7. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S; IDF Consensus Group (2007). The metabolic syndrome in children and adolescents- an IDF consensus report. Pediatric Diabetes. 2007; 8: 299-306.

  8. Day C. Metabolic syndrome, or What you will: definitions and epidemiology. Diabetes and Vascular Disease Research. 2007; 4: 32.

  9. Chen W, Bao W, Begum S, Elkasabany A, Srinivasan SR, Berenson GS. Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: The Bogalusa Heart Study. Diabetes. 2000; 49: 1042-8.

  10. Raitakari OT, Juonala M, Kahonen M et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: The Cardiovascular Risk in Young Finns Study. JAMA. 2003; 290: 2277-83.

  11. Lambert M, Paradis G, O’Loughlin J, Delvin EE, Hanley JA, Levy E. Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes Relat Metab Disord. 2004; 28: 833-41.

  12. Duncan GE, Sierra ML, Xiao-Hua Z. Prevalence and trends of a metabolic syndrome phenotype among U.S. adolescents 1999-2000. Diabetes Care. 2004; 27: 2438-2443.

  13. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz W. Prevalence of a metabolic syndrome phenotype in adolescents: Findings from the third National Health and Nutrition Examination Survey 1988-1994. Arch Pediatr Adolesc Med. 2003; 157: 821-7.

  14. Seo SJ, Lee HY, Lee SW. The Prevalence of the Metabolic Syndrome in Korean Children and Adolescents: Comparisons of the Criteria of Cook et al., Cruz and Goran, and Ferranti et al. Yonsei Med J. 2008; 49 (4): 563-572.

  15. Çizmecioğlu FM, Hatun Ş, Kalaça S. Metabolic syndrome in obese Turkish children and adolescents: comparison of two diagnostic models. Turk J Pediatr. 2008; 50: 359-365.

  16. Chu NF, Rimm EB, Wang DJ, Liou HS, Shieh SM. Clustering of cardiovascular disease risk factors among obese schoolchildren: the Taipei Children Heart Study. Am J Clin Nutr. 1998; 67: 1141-1146.

  17. Lee MS, Wahlqvist ML, Yu HL, Pan WH. Hyperuricemia and metabolic syndrome in Taiwanese children. Asia Pac J Clin Nutr. 2007; 16 (Suppl 2): 594-600.

  18. Li Y, Yang X, Zhai F, Kok FJ, Zhao W, Piao J, Zhang J, Cui Z, Ma G. Prevalence of the metabolic syndrome in Chinese adolescents. Br J Nutr. 2008; 99: 565-570.

  19. López-Capapé M, Alonso M, Colino E, Mustieles C, Corbatón J, Barrio R. Frequency of the metabolic syndrome in obese Spanish pediatric population. Eur J Endocrinol. 2006; 155: 313-319.

  20. Seki M, Matsuo T, Faria CAJ. Prevalence of metabolic syndrome and associated risk factors in Brazilian schoolchildren. Public Health Nutrition. 2008; 2 (7): 947-952.

  21. Bokor S, Frelut ML, Vania A, Hadjiathanasiou CG, Anastasakou M, Melecka-Tendera E et al. Prevalence of metabolic syndrome in European obese children. Int J Pediatr Obes. 2008; 3 (Suppl 2): 3-8.

  22. Csabi G, Torok K, Jeges S, Molnar D. Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr. 2000; 159: 91-4.

  23. Dhuper S, Cohen HW, Daniel J, Gumidyala P, Agarwalla V, Victor R, Dhuper S. Utility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional study. Cardiovascular Diabetology. 2007; 6: 4 doi:10.1186/1475-2840-6-4.

  24. Burrows RA, Leiva BL, Weistaub G, Ceballos X, Gattas ZV, Lera L, Albala C B. Síndrome metabólico en niños y adolescentes: asociación con sensibilidad insulínica y con magnitud y distribución de la obesidad. Rev Med Chile. 2007; 135: 174-181.

  25. Cáceres M, Terán CG, Rodríguez S, Medina MC. Prevalence of insulin resistance and its association with metabolic syndrome criteria among Bolivian children and adolescents with obesity. BMC Pediatrics. 2008; 8: 31.

  26. Ferreira de MCA, Sanchez FC, Netto-Oliveira ER, Fossati RF. Prevalence of metabolic syndrome in adolescents: a systematic review. Cad Saude Publica 2009; 25 (6): 1195-202.

  27. Rodríguez-Moran M, Salazar VB, Violante R, Guerrero RF. Metabolic syndrome among children and adolescents aged 10-18 years. Diabetes Care. 2004; 27: 2516-2517.

  28. Camarillo-Romero E, Domínguez-García MV, Amaya-Chávez A, Huitrón-Bravo G, Majluf-Cruz A. Dificultades en la clasificación del síndrome metabólico. El ejemplo de los adolescentes en México. Salud Publica Mex. 2010; 52: 524-527.

  29. Pajuelo J, Bernui I, Nolberto V, Peña A, Zevillanos L. Síndrome metabólico en adolescentes con sobrepeso y obesidad. An Fac Med Lima. 2007; 68 (2): 144.

  30. Juarez LC, Klünder KM, Medina BP, Madrigal AA, Mass DE, Flores HS. Insulin resistance and its association with the components of the metabolic syndrome among obese children and adolescents. BMC Public Health. 2010; 10: 318.

  31. Velasco-Martínez RM, Jiménez-Cruz A, Higuera Domínguez F, Domínguez de la Piedra E, Bacardí-Gascón M. Obesidad y resistencia a la insulina en adolescentes de Chiapas. Nutr Hosp. 2009; 24 (2): 187-192.

  32. Cardoso-Saldaña GC, Yamamoto-Kimura L, Medina-Urrutia A, Posadas-Sánchez R, Caracas-Portilla NA, Posadas-Romero C. Obesity or overweight and metabolic syndrome in Mexico City teenagers. Arch Cardiol Mex. 2010; 80 (1): 12-18.

  33. Cárdenas-Villareal VM, López-Alvarenga JC, Bastarrachea RA, Rizo-Baeza MM, Cortés-Castell E. Metabolic syndrome prevalence in teenagers of Monterrey, Nuevo León. Arch Cardiol Mex. 2010; 80 (1): 19-26.

  34. Del Rio-Navarro BE, Castro-Rodriguez JA, Garibay Nieto N, Berber A, Toussaint G, Sienra-Monge JJ, Romieu I. Higher metabolic syndrome in obese asthmatic compared to obese nonasthmatic adolescent males. J Asthma. 2010; 47 (5): 501-6.

  35. Elizondo-Montemayor L, Serrano-González M, Ugalde-Casas PA, Bustamante-Careaga H, Cuello-García C. Waist-to-height: cutoff matters in predicting metabolic syndrome in Mexican children. Metab Syndr Relat Disord. 2011; 9 (3): 183-90.

  36. Cornejo BJ, Llanas RJD, Arriaga CHE, Pérez-Laínez S, Pérez-Baez FJ, González OM, Hernández-Hernández DE. Características bioquímicas y metabólicas en familias de niños con obesidad en Tamaulipas. En prensa.

  37. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: The Bogalusa Heart Study. Pediatrics. 1999; 103 (6): 1175-82.

  38. Lambert M, Delvin EE, Levy E, O’Loughlin J, Gilles Paradis, T Barnett T, McGrath JJ. Prevalence of cardiometabolic risk factors by weight status in a population-based sample of Quebec children and adolescents. Can J Cardiol. 2008; 24 (7): 575.

  39. Mitchell BD, Kammerer CM, Blangero J, Mahaney MC, Rainwater DL, Dyke B, Hixson JE et al. Genetic and Environmental Contributions to Cardiovascular Risk Factors in Mexican Americans. The San Antonio Family Heart Study. Circulation. 1996; 94: 2159-2170.




2020     |     www.medigraphic.com